Issue |
J Extra Corpor Technol
Volume 41, Number 2, June 2009
|
|
---|---|---|
Page(s) | 97 - 104 | |
DOI | https://doi.org/10.1051/ject/200941097 | |
Published online | 15 June 2009 |
Abstract
Influence of Cardiopulmonary Bypass on the Interaction of Recombinant Factor VIIa with Activated Platelets
* Hemostasis Biology, Novo Nordisk A/S, Måløv, Denmark
† Heart Center, Department of Thoracic Surgery, Rigshospitalet, Denmark
‡ Regional Blood Bank, Rigshospitalet, Copenhagen, Denmark
Address correspondence to: Pär I. Johansson, Medical Director, Transfusion Service, Regional Blood Bank, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen East, Denmark. E-mail: per.johansson@rh.regionh.dk
Received:
3
December
2008
Accepted:
10
March
2009
Recombinant factor VIIa (rFVIIa) interacts preferentially with coated platelets characterized by a high exposure of phosphatidyl serine (PS), FV, FVIII, FIX, and FX binding, and fibrinogen. Cardiopulmonary bypass (CPB) is known to impair platelet function. In this study, the influence of CPB on formation of coated platelets and the interaction of rFVIIa with the platelets were studied. Blood was either exposed to a closed CPB circuit or obtained from patients undergoing CPB-assisted cardiac surgery, and platelets were analyzed by flow cytometry with and without dual agonist stimulation with thrombin and a GPVI collagen receptor agonist known to induce coated platelet formation. Platelets circulated within a closed CPB circuit did not spontaneously form coated platelets. Dual agonists stimulation caused formation of coated platelets at a reduced level compared to pre-CPB level (51 ± 21% vs. 80 ± 17% before CPB, p < .001). The rFVIIa interaction with the coated platelets was not impaired after CPB. Platelets isolated from patients undergoing CPB-assisted cardiac surgery also formed coated platelets only after dual agonist stimulation but to the same level as before surgery (76 ± 8% vs. 83 ± 14% before surgery, p = .17, n = 10). rFVIIa interaction with the coated platelets was not impaired after surgery. No spontaneous rFVIIa-binding platelets were found. The data indicate that CPB exposure in vivo does not compromise the platelet-dependent effects of rFVIIa either by spontaneous formation of coated platelets, thereby limiting the risk of systemic coagulation, or by impairing rFVIIa interaction with the agonist-induced coated platelets, thereby retaining the hemostatic potential of rFVIIa after CPB.
Key words: cardiopulmonary bypass / P-selectin / fibrinogen / coated platelets / recombinant factor VIIa
© 2009 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.